There’s the Pranjal Gupta dressed in kurta and pyjama, his feet keeping time with an impossibly fast Indian dance tune. And then there’s the Pranjal Gupta in a lab coat, peering through glasses at data on how children with autism integrate sight and sound.

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

The Vanderbilt Kennedy Center (VKC) is one of a select group of sites selected to launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States.

Meagan Quinlan, a Pharmacology graduate student in the laboratory of Randy Blakely, Ph.D., honored her mentor Tuesday during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.

Scientists, physicians, staff members and patients interested in the latest in cancer research are invited to attend the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat to be held Friday, May 6, 8 a.m. – 3 p.m., at the Vanderbilt University Student Life Center.